
The development of new drugs is a complex and costly process, and the preclinical phase is a critical step in ensuring that new therapeutic candidates are safe and effective before they progress to clinical trials. This course aims to provide students with a comprehensive understanding of the essential preclinical concepts of literature, toxicity, and bioimaging.
In the literature component of the course, students will learn how to navigate the vast amount of preclinical literature available to researchers and scientists. They will be introduced to various databases, search engines, and analytical tools to extract relevant information and interpret findings. They will also learn how to critically evaluate preclinical literature and identify gaps in current knowledge.
The toxicity component of the course will introduce students to the fundamental principles of preclinical toxicology and safety assessments. They will learn about different types of toxicity models and how to interpret toxicity data. Students will also gain an understanding of the regulatory requirements for preclinical safety testing, including the use of animal models.
In the bioimaging component of the course, students will learn about the various imaging techniques used in preclinical research. They will be introduced to different imaging modalities, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), and learn how to choose the appropriate imaging modality for different preclinical applications. They will also learn how to interpret imaging data and integrate it with other preclinical data.
At the end of the course, students will have a comprehensive understanding of preclinical literature, toxicity testing, and bioimaging and be equipped with the necessary skills to apply these concepts in their own research.